EFDID: 527938EFD: View Filing

Issuer: Ensho Therapeutics, Inc. (0002032849) - D

Accession: 0002032849-24-000001 (XMLRaw Data) (EDGAREDGAR Files) (Form DForm D)

EDGAR: Issuer Information
  • CIK:
    0002032849
  • Entity Name:
    Ensho Therapeutics, Inc.
  • Entity Type:
    Corporation
  • Jurisdiction:
    DELAWARE
  • Year of Inc:
    Within 5 years (2024)
  • Address:
    422 MOUNTAIN WAY
    MORRIS PLAINS, NY 07950
  • Persons:
    Related Persons 5
    Neena Bitritto-Garg
    Executive Officer, Director, Promoter
    Bittoo Kanwar
    Executive Officer
    James Andrew Whitney
    Executive Officer
    Emily Weng
    Executive Officer
    Matthew McKevitt
    Executive Officer
EDGAR: Offering Information
  • Accession Date:
    08/06/2024
  • First Sale Date:
    07/19/2024
  • Offering Amount:
    $2,000,000
  • Amount Sold:
    $400,000
  • Amount Remaining:
    $1,600,000
  • Exemptions:
    Rule 506
  • Security Type(s):
    simple agreement for future equity.
EFD: Current State Notices
View Notices

Notices found in EFD

Filed:CA, MA, NJ, RI
EDGAR: Sales Compensation Recipient Information

There were no Sales Compensation Recipient Information associated with this Accession Number.

EDGAR: Signatures
IssuerSignatureSigner NameTitleSignatureDate
Ensho Therapeutics, Inc.Neena Bitritto-GargNeena Bitritto-GargPresident and Executive Chair2024-08-06